Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| JOHNSON & JOHNSON | 49,056 | reported | 28 May 2008 | tx 38+356,080−253,735 |
| OptiNose, Inc. | 32,000 | reported | 08 Jun 2022 | tx 12+164,304 |
| ENDO PHARMACEUTICALS HOLDINGS INC | 6,515 | reported | 12 Mar 2013 | tx 36+62,888−7,911 |
| Acurx Pharmaceuticals, Inc. | 2,150 | reported | 20 Apr 2026 | tx 6+123,412 |
| COVANCE INC | 0 | reported | 19 Feb 2015 | tx 38+31,450−33,450 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Apr 2026 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 2,150 | 0.00 USD | deriv |
| 06 Jan 2025 | PURCHASE | Acurx Pharmaceuticals, Inc. | 24,631 | 1.02 USD | first after silence |
| 06 Jan 2025 | PURCHASE | Acurx Pharmaceuticals, Inc. | 24,631 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | OptiNose, Inc. | 32,000 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | OptiNose, Inc. | 14,439 | 0.00 USD | deriv |
| 10 May 2021 | PURCHASE | OptiNose, Inc. | 10,000 | 2.99 USD | first after silence |
| 10 Jun 2020 | GRANT_AWARD | OptiNose, Inc. | 14,439 | 5.65 USD | deriv |
| 06 Mar 2020 | PURCHASE | OptiNose, Inc. | 2,000 | 5.56 USD | |
| 06 Mar 2020 | PURCHASE | OptiNose, Inc. | 6,500 | 5.75 USD | |
| 06 Mar 2020 | PURCHASE | OptiNose, Inc. | 200 | 5.53 USD | anomaly |
| 06 Dec 2019 | PURCHASE | OptiNose, Inc. | 6,100 | 8.22 USD | |
| 06 Jun 2019 | GRANT_AWARD | OptiNose, Inc. | 14,439 | 6.60 USD | deriv |
| 12 Dec 2018 | PURCHASE | OptiNose, Inc. | 6,430 | 7.89 USD | first after silence |
| 11 Jun 2018 | GRANT_AWARD | OptiNose, Inc. | 14,439 | 22.50 USD | deriv |
| 12 Oct 2017 | GRANT_AWARD | OptiNose, Inc. | 43,318 | 0.00 USD | deriv |
| 19 Feb 2015 | OTHER | COVANCE INC | 7,466 | — | |
| 19 Feb 2015 | OTHER | COVANCE INC | 2,800 | — | deriv |
| 19 Feb 2015 | OTHER | COVANCE INC | 2,800 | — | deriv |
| 19 Feb 2015 | OTHER | COVANCE INC | 2,800 | — | deriv |
| 19 Feb 2015 | OTHER | COVANCE INC | 1,700 | — | deriv |
| 20 May 2014 | OTHER | COVANCE INC | 1,505 | 83.78 USD | |
| 20 May 2014 | EXERCISE | COVANCE INC | 1,505 | 0.00 USD |
5 purchases reported after at least 12 months of silence — most recent on 06 Jan 2025.